Curriculum Vitae:
Jeanette Eulalia Cueva, M.D.

ACADEMIC TRAINING

College:
1978 – 1982 B.S. Degree: Fordham University, Bronx, New York. Major in Biology, Minor in Philosophy
1982 – 1986 M.D. Degree: New York Medical College, Valhalla, New York, Medicine
Licensures:
1989 State of New York and Surgical License #180828-1
1991 New York State Dept. of Health, Bureau of Controlled Substances, DEA #BC4014028
Traineeship:
July 1, 1986 – June 30, 1987 Intern, General Psychiatry (PGY I), St. Vincent’s Hospital and Medical Center, New York, NY
July 1, 1987 – June 30, 1990 Resident, General Psychiatry (PGY II-IV), St. Vincent’s Hospital and Medical Center, New York, NY
July 1, 1990 – June 30, 1991 Resident, Child and Adolescent Psychiatry (PGY V), St. Vincent’s Hospital and Medical Center, New York, NY
July 1, 1991 – June 30, 1992 Chief Resident, Child and Adolescent Psychiatry (PGY VI), St. Vincent’s Hospital and Medical Center, New York, NY
June 29, 1992 – June 28, 1993 Research Fellow (PGY VII), Research Training in Child Psychopharmacology, National Institute of Mental Health, Institutional Training Grant (T32 MH 18915), Director, Magda Campbell, MD
Department of Psychiatry, New York University Medical Center, New York, NY
June 29, 1993 – June 28, 1994 Chief Research Fellow (PGY VIII), Research Training in Child Psychopharmacology, National Institute of Mental Health, Institutional Training Grant (T32 MH 18915)
Director, Magda Campbell, MD, Department of Psychiatry, New York University Medical Center, New York, NY
February 1996 – February 1997 Psychoanalytic Psychotherapy Columbia University, Psychoanalytic Institute Director, Don Meyers, MD, Department of Psychiatry, Columbia University and Medical Center
College of Physician and Surgeons, New York, NY

BOARD CERTIFICATIONS

Diplomate of the National Board of Examiners, 1989
American Board of Psychiatry and Neurology in Psychiatry, Certificate #34563, 1991
American Board of Psychiatry and Neurology in Child and Adolescent Psychiatry, Certificate #3212, 1993

PROFESSIONAL ORGANIZATIONS AND SOCIETIES

American Psychiatric Association, 1988 – Present
Spanish American Medical Society, 1989 – Present
American Academy of Child and Adolescent Psychiatry, 1990 – Present
American Association for the Advancement of Science, 1991 – 1994
World Federation for Mental Health, 1992 – 1995
New York County Medical Society, 1993 – 1995
American Psychopathological Association, 1995-Present
Association of Women Psychiatrists, 1997 – Present
Women’s Medical Association of New York City, 1997 – 2000

ACADEMIC APPOINTMENTS

July 1992 – June 1994 Clinical Instructor of Psychiatry, Department of Psychiatry, New York University Medical Center, New York, NY
July 1994 – February 2000 Assistant Professor of Psychiatry, Department of Psychiatry, New York Medical College, Valhalla, NY
March 2000 – August 2002 Associate Professor of Clinical Psychiatry and Behavioral Sciences, Department of Psychiatry, New York Medical College, Valhalla, NY
August 2002 – Present Adjunct Associate Professor of Clinical Psychiatry and Behavioral Sciences, Department of Psychiatry, New York Medical College, Valhalla, NY
August 2002 – Present Associate Clinical Professor of Psychiatry, Department of Psychiatry, Columbia University, College of Physicians and Surgeons, New York, NY

HOSPITAL AND CLINICAL APPOINTMENTS

July 1986 – June 1990 General Psychiatry Resident; House Staff, Department of Psychiatry, St. Vincent’s Hospital and Medical Center, New York, NY
July 1990 – June 1991 First Year Child and Adolescent Psychiatry Resident; House Staff, Department of Psychiatry, St. Vincent’s Hospital and Medical Center, New York, NY
July 1991 – June 1992 Second Year Child and Adolescent Psychiatry Chief Resident; Department of Psychiatry, House Staff, Department of Psychiatry, St. Vincent’s Hospital and Medical Center, New York, NY
July 1994 – June 1997 Chief, Child Psychiatry Inpatient Service, Department of Psychiatry, St. Vincent’s Hospital and Medical Center, New York, NY
July 1997 – August 2000 Chief, Child and Adolescent Psychiatry Outpatient Service, Department of Psychiatry, St. Vincent’s Hospital and Medical Center, New York, NY
August 2000 – November 2001 Chief, Child and Adolescent Service, Department of Psychiatry, St. Vincent’s Catholic Medical Centers-Manhattan Region, New York, NY
November 2001 – June 2002 Medical Director, Child and Adolescent Psychiatry Outpatient Service, Department of Psychiatry, St. Vincent’s Catholic Medical Centers-Manhattan Region, New York, NY
August 2002 – Present Medical Director, Integrated Mental Health/Primary Care program (IMP), Division of Child and Adolescent Psychiatry, Department of Psychiatry and Ambulatory Care Network Corporation (ACNC), New York Presbyterian Hospital, New York, NY

HONORS AND AWARDS

Honor al Merito, award presented by Ateneo Ecuatoriano de Nueva York Inc., October 11, 1986
American College of Neuropsychopharmacology (ACNP)/NIMH Minority Travel Award, 1991
Nancy C.A. Roeske, M.D., Certificate of Excellence, presented at the 152nd Annual Meeting of the APA, 1999
Top Doctors of New York Metro Area, Selected by Castle Connolly Medical Ltd., 2001

FELLOWSHIP AND GRANT SUPPORT

Research Activities 1992-1994:
1. Double-blind and Placebo Controlled Study of Carbamazepine in Aggressive Children with
Conduct Disorder. Preceptor, Magda Campbell, M.D.
2. Long-term Prospective Study of Haloperidol and Tardive Dyskinesia in Autistic Children. Preceptor, Magda Campbell, M.D.
3. Double-blind and Placebo Controlled Study of Naltrexone in Autistic Children. Preceptor, Magda
Campbell, M.D.
4. Plasma Beta-Endorphin Levels in Autistic Children. Preceptor, Magda Campbell, M.D.
5. Clomipramine in Autistic Children. Preceptor, Magda Campbell, M.D.
6. Molecular and Linkage Genetics in Autism. Preceptor, Magda Campbell, M.D. (Collaborative Study with Roland D. Ciaranello, M.D., Stanford University).

Research Grants:

1. A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of BMS-562086 in the Treatment of Outpatients with Major Depressive Disorder. Principal Investigator: David Sert Krakow, M.D., Co-Investigator: Jeanette E. Cueva, M.D.; Sponsor: Bristol-Myers Squibb Pharmaceutical Research Institute; March 2007-September 2007

2. A Multi-center, 10-Week, Randomized, Double-blind Study of Sertraline and Placebo in Children and Adolescents with Post-traumatic Stress Disorder. Principal Investigator: Jeanette E. Cueva, M.D., Co-Investigator: David Sert Krakow, M.D.; Sponsor: Pfizer Pharmaceuticals Group; January 2003 – September 2007

3. A Multi-center, Randomized, Double-blind, Placebo-controlled Study with Two Fixed Oral Doses of Aripiprazole (10mg or 30mg) in the Treatment of Adolescent Patients with Schizophrenia. Principal Investigator: Jeanette E. Cueva, M.D., Co-Investigator: David Sert Krakow, M.D.; Sponsor: Otsuka Maryland Research Institute, Inc.

4. A Multi-center, Randomized, Double-blind, Placebo-controlled Study of Two Fixed Oral Doses of Aripiprazole (10mg or 30mg) in the Treatment of Child and Adolescent Patients Aged 10–17 Years, with Bipolar I Disorder, Manic or Mixed Episode with or without Psychotic Features. Principal Investigator: Jeanette E. Cueva, M.D., Co-Investigator: David Sert Krakow, M.D.; Sponsor: Otsuka Maryland Research Institute, Inc.

5. A Multi-center, Open-label Safety and Tolerability Study of Flexible-Dose Oral Aripiprazole (2mg – 30mg) in the Treatment of Adolescent Patients with Schizophrenia, and Child and Adolescent Patients with Bipolar I Disorder, Manic or Mixed Episode. Principal Investigator: Jeanette E. Cueva, M.D., Co-Investigator: David Sert Krakow, M.D.; Sponsor: Otsuka Maryland Research Institute, Inc.

6. A Double-blind Multi-center Study Comparing The Safety and Efficacy of Ziprasidone to Olanzapine in Patients with Schizophrenia or Schizoaffective Disorder Needing Inpatient Care. Principal Investigator: Jeanette E. Cueva, M.D., Co-Investigator: David Sert Krakow, M.D.; Sponsor: Pfizer/Scirex; April 2000 – August 2000

7. A Double-blind, 12-Month Continuation Protocol for Patients who Successfully Completed Protocol RO548. Principal Investigator: Jeanette E. Cueva, M.D., Co-Investigator: David Sert Krakow, M.D.; Sponsor: Pfizer/Scirex; April 2000 – August 2001

8. Olanzapine Plus Fluoxetine Combination Therapy in Treatment Resistant Depression: A Dosing Range Study: Principal Investigator: Jeanette E. Cueva, M.D., Co-Investigator: David Sert Krakow, M.D.: Sponsor: Eli Lilly and Co.; March 2000 – July 2002

9. A Multi-center, Randomized, Double-blind Study of Flexible Doses of Aripriprazole vs. Perphenazine in the Treatment of Patients with Treatment-Resistant Schizophrenia. Principal Investigator: Jeanette E. Cueva, M.D., Co-Investigator: David Sert Krakow, M.D.; Sponsor: Bristol Myers Squibb; August 2000 – July 2002

10. A Multi-center, Randomized, Double-blind Study and Tolerability Study of Flexible Doses of Aripiprazole and Olanzapine in the Treatment of Patients with Acute Schizophrenia. Principal Investigator: Jeanette E. Cueva, M.D., Co-Investigator: David Sert Krakow, M.D.; Sponsor: Bristol Myers Squibb; October 2000 – July 2002

11. The Efficacy and Safety of Risperidone in the treatment of children and adolescents with schizophrenia. Principal Investigator: Jeanette E. Cueva, M.D.; Sponsor: Janssen/Medex; April 2001 – July 2002

12. Olanzapine vs. Risperidone in the treatment of Bipolar I disorder, mixed or manic. Principal Investigator: Jeanette E. Cueva, M.D., Co-Investigator: David Sert Krakow, M.D.; Sponsor: Eli Lily & Company; August 2001 – July 2002

13. Olanzapine vs. Ziprasidone in the treatment of Schizophrenia. Principal Investigator: Jeanette E. Cueva, M.D., Co-Investigator: David Sert Krakow, M.D.; Sponsor: Eli Lily & Company; August 2001 – July 2002

14. A comparison of fasting triglyceride levels cohorts with schizophrenic and related disorder treated chronically with Olanzapine, Risperidone and typical anti-psychotics. Principal Investigator: Jeanette E. Cueva, M.D., Co-Investigator: David Sert Krakow, M.D.; Sponsor: Eli Lily & Company; August 2001 – April 2002

15. A Phase III, Randomized, Multi-center, Double-blind, Parallel-group, Placebo-controlled Safety and Efficacy Study of SPD503 in Children and Adolescents aged 6–17 with Attention Deficit Hyperactivity Disorder. Principal Investigator: Jeanette E. Cueva, M.D., Co-Investigator: David Sert Krakow, M.D.; Sponsor: Shire Pharmaceutical Development, Inc.

16. A Phase III, Open-label Study of SPD503 in Children and Adolescents aged 6–17 with Attention Deficit Hyperactivity Disorder. Principal Investigator: Jeanette E. Cueva, M.D., Co-Investigator: David Sert Krakow, M.D.; Sponsor: Shire Pharmaceutical Development, Inc.

17. A Phase III, Randomized, Multi-center, Double-blind, Parallel-group, Placebo-controlled Safety and Efficacy Study of ADDERALL XR® with an Open-label Extension, in the Treatment of Adolescents Aged 13–17 with Attention Deficit Hyperactivity Disorder (ADHD). Principal Investigator: Jeanette E. Cueva, M.D., Co-Investigator: David Sert Krakow, M.D.; Sponsor: Shire Pharmaceutical Development, Inc.

18. Olanzapine vs. Placebo in the Treatment of Mania in Adolescents with Bipolar I Disorder. Principal Investigator: Jeanette E. Cueva, M.D., Co-Investigator: David Sert Krakow, M.D.; Sponsor: Eli Lilly & Company

19. Olanzapine vs. Placebo in the Treatment of Adolescents with Schizophrenia. Principal Investigator: Jeanette E. Cueva, M.D., Co-Investigator: David Sert Krakow, M.D.; Sponsor: Eli Lilly & Company

20. The Study of Olanzapine plus Fluoxetine in Combination for Treatment-resistant Depression Without Psychotic Features. Principal Investigator: Jeanette E. Cueva, M.D., Co-Investigator: David Sert Krakow, M.D.; Sponsor: Eli Lilly & Company

21. Population Pharmacokinetic Study in Adolescent Patients with Schizophrenia or Bipolar I Disorder Treated with Olanzapine. Principal Investigator: David Sert Krakow, M.D., Co-Investigator: Jeanette E. Cueva, M.D.; Sponsor: Eli Lilly & Company

COMMITTEE APPOINTMENTS

Member, Clinical Care Committee, Department of Psychiatry, St. Vincent’s Hospital and Medical Center, New York, NY: July 1987 – June 1988
Founding Member, Management and Resident Liaison Committee, Department of Psychiatry and the House Staff, St. Vincent’s Hospital and Medical Center, New York, NY: July 1988 – June 1989
Member, Management and Resident Liaison Committee, Department of Psychiatry, St. Vincent’s Hospital and Medical Center, New York, NY: July 1989 – June 1990
Member, Utilization Review Committee, Department of Psychiatry, St. Vincent’s Hospital and Medical Center, New York, NY: July 1990 – June 1991
Member, Clinical Care Committee, Department of Psychiatry; Extended Training Committee, Department of Psychiatry; Management and Resident’s Liaison Committee, Department of Psychiatry; Residency Training Committee, Department of Psychiatry; Executive Committee, Department of Psychiatry and Attending Faculty and Service Chiefs Workgroups, Department of Psychiatry, St. Vincent’s Hospital and Medical Center, New York, NY: July 1991 – June 1992
Member, Residency Recruitment Committee, Department of Psychiatry; Clinical Studies Committee, Department of Psychiatry; Child Residency Training Committee, Department of Psychiatry; Medical Staff Work Group, Department of Psychiatry and Administrative Committee, Department of Psychiatry; St. Vincent’s Hospital and Medical Center, New York, NY: July 1994 – June 2002
Member, Research Committee of St. Vincent’s Hospital and Medical Center, New York, NY: January 1996 – June 2002
Faculty Senator at New York Medical College, Valhalla, NY: July 1997 – June 2002
Member, Utilization Review Committee, Department of Psychiatry; Medical Student and Residency Training Committee, Department of Psychiatry, and General Medical Education Committee, St. Vincent’s Hospital and Medical Center, New York, NY: September 1997 – June 2002
Member, Internal Review Board of St. Vincent’s Hospital and Medical Center, New York, NY: July 1999 – June 2002
Member, Clinical Care Committee, Department of Psychiatry, St. Vincent’s Hospital and Medical Center, New York, NY: August 2000 – June 2002

DEPARTMENTAL COMMITTEES

Member, Clinical Care Committee, Department of Psychiatry, St. Vincent’s Hospital and Medical Center, New York, NY: July 1987 – June 1988
Founding Member, Management and Resident Liaison Committee, Department of Psychiatry and the House Staff, St. Vincent’s Hospital and Medical Center, New York, NY: July 1988 – June 1989
Member, Management and Resident Liaison Committee, Department of Psychiatry, St. Vincent’s Hospital and Medical Center, New York, NY: July 1989 – June 1990
Member, Utilization Review Committee, Department of Psychiatry, St. Vincent’s Hospital and Medical Center, New York, NY: July 1990 – June 1991
Member, Clinical Care Committee, Department of Psychiatry; Extended Training Committee, Department of Psychiatry; Management and Resident’s Liaison Committee, Department of Psychiatry; Residency Training Committee, Department of Psychiatry; Executive Committee, Department of Psychiatry and Attending Faculty and Service Chiefs Workgroups, Department of Psychiatry, St. Vincent’s Hospital and Medical Center, New York, NY: July 1991 – June 1992
Member, Residency Recruitment Committee, Department of Psychiatry; Clinical Studies Committee, Department of Psychiatry; Child Residency Training Committee, Department of Psychiatry; Medical Staff Work Group, Department of Psychiatry and Administrative Committee, Department of Psychiatry; St. Vincent’s Hospital and Medical Center, New York, NY: July 1994 – June 2002
Member, Utilization Review Committee, Department of Psychiatry; Medical Student and Residency Training Committee, Department of Psychiatry, and General Medical Education Committee, St. Vincent’s Hospital and Medical Center, New York, NY: September 1997 – June 2002
Member, Clinical Care Committee, Department of Psychiatry, St. Vincent’s Hospital and Medical Center, New York, NY: August 2000 – June 2002

ADMINISTRATIVE APPOINTMENTS

February 2000 – November 2001: Manager, Child and Adolescent Psychiatry Outpatient Service, St. Vincent’s Catholic Medical Centers-Manhattan Region, New York, NY

TEACHING EXPERIENCE

Clinical teaching and supervision of Medical Student in Inpatient and Outpatient General Psychiatry, St. Vincent’s Hospital and Medical Center, New York, NY, July 1986 – June 1990
Clinical teaching and supervision of Medical Students and General Psychiatry Residents in Inpatient and Outpatient Child Psychiatry, St. Vincent’s Hospital and Medical Center, NY, NY, July 1990 – June 1992
Preceptor to second year Medical Students as part of the course entitled Introduction to Psychopathology, New York University School of Medicine, New York, NY, July 1992 – February 1993
Supervision of third and fourth year General Psychiatry Residents; first and second year Child Psychiatry Residents in Outpatient Child Psychiatry, St. Vincent’s Hospital and Medical Center, New York, NY, September 1994 – June 2002
Supervision of first year Child Psychiatry Resident and second year General Psychiatry Resident in Inpatient Child Psychiatry, St. Vincent’s Hospital and Medical Center, New York, NY, September 1994 – June 1997
Research Practicum in Child and Adolescent Psychiatry; Course given to first and second year Child Psychiatry Residents, Department of Psychiatry, St. Vincent’s Hospital and Medical Center, New York, NY, September 1994 – June 2002
Introduction to Child Psychiatry; Course given to third year Medical Students, New York Medical College, Valhalla, NY, September 1994 – February 2000
Mental Retardation and the Pervasive Developmental Disorders; Course given to third year General Psychiatry Residents, St. Vincent’s Hospital and Medical Center, New York, NY, January 1995 – February 2000
Introduction to Behavioral Science; Course given to first year Medical Students, New York Medical College, Valhalla, NY, May 1995 – February 2000;May 2001
Conduct Disorder; Lecture given to first and second year General Psychiatry Residents and Pediatric Residents, Saint Vincent’s Hospital and Medical Center, New York, NY, July 1995 – June 2001
Pediatric Psychopharmacology; Lecture given to second year General Psychiatry Residents, St. Vincent’s Hospital and Medical Center, New York, NY, January 1996 – December 1999
Attention Deficit/Hyperactivity Disorder; Lecture given to first and second year General Psychiatry Residents and Pediatric Residents, St. Vincent’s Hospital and Medical Center, New York, NY, January 1996 – June 2001
Oppositional Defiant Disorder; Lecture given to second year General Psychiatry Residents, St. Vincent’s Hospital and Medical Center, New York, NY, January 1996 – June 2001
Mental Retardation; Lecture given to second year General Psychiatry Residents, St. Vincent’s Hospital and Medical Center, New York, NY, January 1996 – February 2000
Autism and PDD; Lecture given to second and fourth year General Psychiatry Residents and Pediatric Residents, St. Vincent’s Hospital and Medical Center, New York, NY, March 1996 – February 2000
Aggression and Conduct Disorders in Children; Lecture given to Child and Adolescent Psychiatry Residents, New York Hospital-Cornell Medical Center, New York, NY, March 5, 1996
Aggression and Conduct Disorders in Children; Lecture given to fourth year General Psychiatry Residents, St. Vincent’s Hospital and Medical Center, New York, NY, October 1996 – October 2000
Inpatient Child Psychiatry; Lecture given to fourth year General Psychiatry Residents, St. Vincent’s Hospital and Medical Center, New York, NY, October 1996 – October 1999
Conduct Disorder; Lecture given to first year medical students, New York Medical College, Valhalla, NY, May 1997 – Present
Child and Adolescent Psychopharmacology; Course given to first and second year Child and Adolescent Psychiatry Residents, St. Vincent’s Hospital and Medical Center, New York, NY, September 1997 – September 2000
Human Development; Course given to PGY-II General Psychiatry Residents, St. Vincent’s Hospital and Medical Center, New York, NY, November 1997 – December 1999
Attention Deficit Hyperactivity Disorder; Lecture given to first year medical student, New York Medical College, Valhalla, NY, May 31, 2002
Child Abuse; Lecture given to first year medical students, New York Medical College, Valhalla, NY, May 31, 2002
Child Abuse; Lecture given to PGY-III General Psychiatry Residents; St. Vincent’s Hospital and Medical Center; New York, NY, June 11, 2002

DISSERTATION SUPERVISED

Title: An Examination of Attachment, Affective Functioning and Social Information Processing in Children with Conduct Disorder; Institution: Farleigh Dickinson University, Psychology; Candidate: Jeanne Marron; Date: July 1997 – July 1999

DISSERTATION COMMITTEE SERVED ON

OTHER PROFESSIONAL ACTIVITIES

Membership on Board of Directors:
New York Council of Child and Adolescent Psychiatry, May 1995 – February 2002
New York Council of Child and Adolescent Psychiatry, September 2002 – Present

Membership on Advisory Board:
Pfizer Pharmaceuticals, 1998

Reviewer for Scientific Journals:
1. Journal of the American Academy of Child and Adolescent Psychiatry, January 1995 – Present
2. Comprehensive Journal of Psychiatry, May 1995

Membership On Speaker Panel:
Pfizer Pharmaceuticals, 1998
Parke-Davis, 1998

BIBLIOGRAPHY:

Original Peer Review Articles:
1. *O’Connell, RA, Sereci, Jr, SN, Fastov, ME, Cueva, JE, Luck, D, Nathanson, MR and Van Heertum, R. The Role of SPECT Brain Imaging in Assessing Psychopathology in the Medically Ill. General Hospital Psychiatry, 13:305 – 312, 1991.
2. *Shay, J, Sanchez, LE, Cueva, JE, Armenteros, JL, Overall, JE and Campbell, M. Neuroleptic-Related Dyskinesias and Stereotypies in Autistic Children: VideotapeD Ratings. Psychopharmacoly Bulletin, Vol. 29, No. 3, 1993, pp 359 – 363.
3. *O’Connell, RA, Van Heertum, RL, Luck, D, Yudd, AP, Cueva, JE, Billick, SB, Cordon, DJ, Gersh, RJ, Masdeu, JC. Single-Photon Emission Computed Tomography of the Brain in Acute Mania and Schizophrenia. J. Neuroimag 1995; 5:101 – 104.
4. *Sanchez, LE, Campbell, M, Small, AM, Cueva, JE, Armenteros, JL and Adams, PB. A Pilot Study of Clomipramine in Young Autistic Children. J. Am. Acad. Child Adolesc. Psychiatry, 35:4, April 1996, 537 – 544.
5. *Cueva, JE, Overall, JE, Small, AM, Armenteros, JL, Perry, R and Campbell, M. Carbamazepine in Aggressive Children with Conduct Disorder: A Double-Blind and Placebo-Controlled Study. J.Am Acad. Child Adolesc.Psychiatry, 35: 4, April 1996, 480 – 490.

Chapters and Books:
1. Campbell, M, Cueva, JE and Hallin, A. Autism/Developmental Disorders. JW Wiener (Ed.), In: Diagnosis and Psychopathology of Childhood and Adolescent Disorders; Wiley, New York, NY, 1996; pp 151 – 192
2. Campbell, M, Cueva, JE, and Adam, PB. Pharmacotherapy of Impulsive-Aggressive Behavior. CR Cloninger (Ed.), In: Personality and Psychopathology; American Psychiatric Press, 1999; Washington, DC; pp. 431 – 455

Reviews and Editorial:
1. Campbell, M and Cueva, JE. Psychopharmacology in Child and Adolescent Psychiatry: A Review of the Past Seven Years, Part I. J. Amer. Acad. Child Adolesc. Psychiatry, 1995, September, 34(9): 1124 – 1132
2. Campbell, M and Cueva, JE. Psychopharmacology in Child and Adolescent Psychiatry: A Review of the Past Seven Years, Part II. J. Amer. Acad. Child Adolesc. Psychiatry, 1995, 34(10); 1262 – 1272
3. Campbell, M, Kafantaris, V and Cueva, JE. An Update on the Use of Lithium Carbonate in Aggressive Children and Adolescents with Conduct Disorders. Psychopharmacol. Bulletin, 1995, 31(1); 93 – 102
4. Campbell, M, Schopler, E, Cueva, JE, and Hallin, A. Treatment of Autistic Disorder. J. Amer. Acad. Child Adolesc. Psychiatry, 1996, 35(2); 134 – 143

Letters To The Editor:
1. Lykes, WC and Cueva, JE, Risperidone in Childhood Schizophrenia. J. Amer. Acad. Child Adolesc. Psychiatry, Letter to the Editor, 3594); pp 405 – 406, 1996.

Abstracts:
1. O’Connell, R, Sereci, Jr. S., Fastov, M, Cueva, JE, Luck, D, Nathanson, M and van Heertum, R. SPECT Brain Imaging in Bipolar Manic. New Research and Abstracts, The 146th Annual Meeting of the American Psychiatric Association, Washington, DC, May 1992.
2. Campbell, M, Sanchez, LE, Shay, J, Cueva, JE, and Armenteros, JL. Tardive Dyskinesia in Children. Abstracts. The 5th Annual New York State Office of Mental Health Research Conference, December 7 – 9, 1992, NY, p. 32.
3. Shay, J, Sanchez, LE, Cueva, JE, Armenteros, JL, Overall, JE and Campbell, M. Neuropleptic-related Dyskinesias and Sterotypies in Autistic Children: Videotape Ratings. Abstracts of Panels and Posters, 31st Annual Meeting of the American College of Neuropsychopharmacology, San Juan, PR, December 14 – 18, 1992, p. 188.
4. Cueva, JE, Armenteros, JL, Rosenberg, AM and Campbell, M. Untoward Effects of Carbamazepine in Hospitalized Aggressive Children with Conduct Disorder. Neuropsychopharmacology First International Congress on Hormones, Brain and Neuropsychopharmacology, Rhodes, Greece, September 15, 1993, Vol. 9, no. 2S, p. 94s.
5. Armenteros, JL, Cueva, JE, Sanchez, LE, Adams P and Campbell, M. Early vs. Late Onset Neuroleptic-related Dyskinesias in Autistic Children: Preliminary Findings. Neuropsychopharmacology, First International Congress on Hormones, Brain and Neuropsychopharmacology, Rhodes, Greece, September 15, 1993, vol. 9, no. 2S, p. 94s.
6. Cueva, JE, Rosenberg, CR, and Campbell, M. Placebo Responders during Baseline as Rated on the Overt Aggression Scale. Scientific Proceedings of the Annual Meeting, 40th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, San Antonio, TX, October 30, 1993, vol. IX, p. 64.
7. Sanchez, LE, Cueva, JE, Armenteros, JL and Campbell, M. Untoward Effects and Their Clinical Management in Young Autistic Children Treated with Clomipramine. New Research Program and Abstracts, 147th Annual Meeting of the American Psychiatric Association, Philadelphia, PA, May 23, 1994, p. 86.
8. Cueva, JE, Campbell, M, Adams, PB and Small, AM. The Overt Aggression Scale: A Useful Instrument for Capturing Aggressiveness. Scientific Proceedings of the Annual Meeting, 41st Annual Meeting of the American Academy of Child and Adolescent Psychiatry, New York, NY, October 29, 1994, p. 71.
9. Sanchez, LE, Cueva, JE, Armenteros, JL and Campbell, M. A Pilot Study of Clomipramine in Hospitalized Autistic Children. Scientific Proceeding of the Annual Meeting, 41st Annual Meeting of the American Academy of Child and Adolescent Psychiatry, New York, NY, October 28, 1994, p. 68.
10. Geller, B, Sverd, J, Frazier, Walsh, BT, Liebowitz, M, Greenhill, L and Cueva, JE. Advance Topics in Psychopharmacology. Scientific Proceedings of the Annual Meeting, 42nd Annual Meeting of the American Academy of Child and Adolescent Psychiatry, New Orleans, LA, October 22, 1995, p. 12.
11. Cueva, JE,. Carbamazepine in Children with Aggressive Conduct Disorder. Scientific Proceedings of the Annual Meeting, 42nd Annual Meeting of the American Academy of Child and Adolescent Psychiatry, New Orleans, LA, October 22, 1995, p. 13.
12. Cueva, JE, Marron, J, Rackow, L, Pazur, B, Eth S. Depakote Rapid Stabilization in Bipolar Adolescents. Scientific Proceedings of the Annual Meeting, 45th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Anaheim, CA, October 28, 1998, p. 99.